DCC Health & Beauty Solutions Ltd.

DCC Health & Beauty Solutions Ltd.

DCC Health & Beauty Solutions Ltd. operates as the holding entity for HBI Group, a contract development and manufacturing organization (CDMO) in the health and wellness sector. The firm's origins trace to its acquisition by Ourvita Group, announced in recent months, which folded HBI into one of Europe's largest diversified CDMO platforms for health and wellness. HBI Group manufactures across 13 product categories, including body care, facial skin care, capsules, chewables, effervescent tablets, gummies, soft gels, nutritional liquids, powders, tablets, hair care, medical devices, and OTC medicines. Each of the seven operating subsidiaries — HBI Amerilab Technologies, HBI Bittner, HBI Design Plus, HBI EuroCaps, HBI Ion Labs, HBI Laleham, and HBI Thompson & Capper — specializes in specific product formats. Facilities span the US and Europe, and the group reports 452 years of combined operational expertise (per the firm, 2025). Employment estimates exceed 600 across the group; HBI Laleham alone claims over 600 professionals (per HBI website, 2025). The group operates 1.2 million square feet of manufacturing space. All sites run on 100% renewable electricity, with solar panels at three locations. A recent announcement confirmed HBI became part of Ourvita Group, creating a platform combining HBI's contract manufacturing capabilities with Ourvita's European CDMO network (per HBI news, May 2025). The structural differentiator is its operating-company architecture: DCC Health & Beauty Solutions Ltd. holds a diversified manufacturing group covering health, beauty, and pharma. Unlike a traditional single-family office focused on financial asset allocation, this entity generates returns through operational ownership of production assets, with direct control over formulation, regulatory compliance, and supply chain.